Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Meek

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Rapid drug tolerance and dramatic sterilizing effect of moxifloxacin monotherapy in a novel hollow-fiber model of intracellular Mycobacterium kansasii diseaseShashikant Srivastava, Jotam Pasipanodya, Carleton M Sherman, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2013
Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congenersSandirai Musuka, Shashikant Srivastava, Chandima Wasana Siyambalapitiyage Dona, et al.
Journal of Cardiovascular Pharmacology|June 4, 2008
Effects of atazanavir/ritonavir or fosamprenavir/ritonavir on the pharmacokinetics of rosuvastatinAnthony J Busti, Amy M Bain, Ronald G Hall, et al.
Pregnancy Hypertension|March 11, 2018
Pharmacokinetics of amlodipine besylate at delivery and during lactationJamie L Morgan, Benjamin K Kogutt, Claudia Meek, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2012
The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistanceAurelia M Schmalstieg, Shashikant Srivastava, Serkan Belkaya, et al.
Lung Cancer (Amsterdam, Netherlands)|October 18, 2015
Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancerDavid E Gerber, David A Boothman, Farjana J Fattah, et al.
Gastroenterology|March 23, 2010
Ribavirin improves early responses to peginterferon through improved interferon signalingJordan J Feld, Glen A Lutchman, Theo Heller, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Rapid drug tolerance and dramatic sterilizing effect of moxifloxacin monotherapy in a novel hollow-fiber model of intracellular Mycobacterium kansasii diseaseShashikant Srivastava, Jotam Pasipanodya, Carleton M Sherman, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2013
Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congenersSandirai Musuka, Shashikant Srivastava, Chandima Wasana Siyambalapitiyage Dona, et al.
Journal of Cardiovascular Pharmacology|June 4, 2008
Effects of atazanavir/ritonavir or fosamprenavir/ritonavir on the pharmacokinetics of rosuvastatinAnthony J Busti, Amy M Bain, Ronald G Hall, et al.
Pregnancy Hypertension|March 11, 2018
Pharmacokinetics of amlodipine besylate at delivery and during lactationJamie L Morgan, Benjamin K Kogutt, Claudia Meek, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2012
The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistanceAurelia M Schmalstieg, Shashikant Srivastava, Serkan Belkaya, et al.
Lung Cancer (Amsterdam, Netherlands)|October 18, 2015
Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancerDavid E Gerber, David A Boothman, Farjana J Fattah, et al.
Gastroenterology|March 23, 2010
Ribavirin improves early responses to peginterferon through improved interferon signalingJordan J Feld, Glen A Lutchman, Theo Heller, et al.
Pageof 2